Abstract: A therapeutic agent for subarachnoid hemorrhage or a drug for improving prognosis of subarachnoid hemorrhage, comprising a compound having a PAR1 inhibitory effect, its pharmaceutically acceptable salt or a hydrate thereof
Type:
Application
Filed:
June 17, 2009
Publication date:
March 11, 2010
Applicants:
Eisai R&D Mangement Co., Ltd., Kyushu University, National University Corporation